Change in antibiotic regimen for emerging multidrug resistance in nosocomial ascitic fluid infection
Author:
- 21 November 2019
- journal article
- editorial
- Published by Springer Nature in Hepatology International
- Vol. 14 (1) , 1-4
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Ascitic fluid infection in children with liver disease: time to change empirical antibiotic policyHepatology International, 2019
- Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis WorldwideGastroenterology, 2019
- Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients WithE coliorKlebsiella pneumoniaeBloodstream Infection and Ceftriaxone ResistanceJAMA, 2018
- Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 2018
- Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremiaWorld Journal of Gastroenterology, 2016
- The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trialHepatology, 2015
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective studyHepatology, 2011
- Management of adult patients with ascites due to cirrhosisHepatology, 2009